CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment of $0 for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Roll Forwards
us-gaap:DefinedBenefitPlanCurtailments · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, benefit obligation, (increase) decrease for curtailment for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, benefit obligation, (increase) decrease for curtailment for fiscal 2024 was $7.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, benefit obligation, (increase) decrease for curtailment for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. defined benefit plan, benefit obligation, (increase) decrease for curtailment for fiscal 2022 was $2.48M.
| Period end | Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Curtailment 12 month |
|---|---|
| 2025-12-27 | $0.00 10-K · filed 2026-02-18 |
| 2024-12-28 | $7.00K 10-K · filed 2026-02-18 |
| 2023-12-30 | $0.00 10-K · filed 2025-02-19 |
| 2022-12-31 | $2.48M 10-K · filed 2024-02-14 |
| 2021-12-25 | $0.00 10-K · filed 2023-02-22 |
| 2017-12-30 | $0.00 10-K · filed 2018-02-13 |
| 2016-12-31 | $279.00K 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |